Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene

ConclusionIn conclusion, late Na+ current blockers appear a promising specific pharmacological treatment of FHM3.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research